(Last updated : 2024-03-25 17:13:41)
  志賀 智子
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  
   Position   Associate Professor
■ Books
1. Chapter contribution  IV Internal Medical Care. IV-1. Managing Lifestyle Diseases., Guide for the Management of Thalidomide Embryopathy 2017 2018
■ Published papers
1. Original article  Urinary afamin levels are associated with the progression of diabetic nephropathy. 2019
2. Original article  Proteomic analysis of serum biomarkers for prediabetes using the Long-Evans Agouti rat, a spontaneous animal model of type 2 diabetes mellitus. 2017/09
3. Original article  Multicenter investigation of lifestyle-related diseases and visceral disorders in thalidomide embryopathy at around 50 years of age. 2015/09
4. Original article  Bone Turnover Markers and Risk Factors Associated with Osteoporosis and Decreased Bone Mass 2014/03
5. Original article  Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver. 2013/12
Display all(12)
■ Academic conference presentation
1. Acutual Health Conditions of Japanese Thalidomiders  2018/09/19
2. Multicentre Survey of Thalidomide Embryopathy (TE) at around 50 years of age in Japan.  2015/11
3. Diseases Affecting Thalidomide Embryopathy at around 50 years of Age.  2015/06/29
4. Molecular mechanisms for TGF-β mediated growth suppression in hepatocellular carcinoma cell lines.  2000/10
5. Synthetic polymer PVLA rescured anoikis in rat hepatocytes.  2000/10
■ Education
1. Faculty of Medicine, Tokyo Women's Medical University, Graduated,